BeStock  
Stocks › Biotechnology › ANRO

Alto Neuroscience ANRO

US equityMarket cap rank #3145Biotechnology
$25.37 −$1.14 (-4.30%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.37 0.00%
Open$25.76
Prev close$26.51
Day range$24.40 – $26.48
Volume522.5K
Market cap$1.02B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-12.7x
CheapRich

Near the bottom of its 5-year range · 5th percentile, 5-year average -6.1x

Price / book4.0x
CheapRich

Above its usual level · 75th percentile, 5-year average 1.6x

#4125 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-17x-11x-5x1xJan '24Jun '25Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$40.09
Price vs. fair value-36.7%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 4.00 – 1.56 75% (pricier than usual) #4125 of 5329 (1 = cheapest)
PE -12.73 -9.12 -6.15 5% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ANRO.

Sign in to join the discussion.

Scroll to Top